EUVIMEDEUVIMED entdecken
Multizentrische Studie

Prognostic Value of a Composite Score Incorporating Baseline [ 18 F]FDG PET/CT and [ 68 Ga]Ga-PSMA-11 PET/CT When Screening for [ 177 Lu]Lu-PSMA Treatment Eligibility (PROFILE Study)

Adrien Jougla, Prescillia Nunes, Anne-Laure Giraudet, Anaïs Olivier, Julie Blanc, Alexandre Cochet, Sylvain Ladoire, Jean-Marc Vrigneaud, Lavinia Vija-Racaru, Clément Drouet

Journal of Nuclear Medicine · 16.07.2026 · jnumed.126.272368

DOI: 10.2967/jnumed.126.272368 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 16.07.2026. Verfasst von Adrien Jougla und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Université Bourgogne Europe, Centre Georges-François Leclerc, Dijon, France. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18, Prostatic Neoplasms, Castration-Resistant, Heterocyclic Compounds, 1-Ring. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyFluorodeoxyglucose F18Prostatic Neoplasms, Castration-ResistantHeterocyclic Compounds, 1-RingEdetic AcidLutetiumDipeptidesHumansGallium RadioisotopesGallium IsotopesPrognosisMaleRetrospective StudiesAgedMiddle AgedRadioisotopesAged, 80 and overNeoplasm Metastasis

Stichwörter der Autor:innen

[177Lu]Lu-PSMA-617[18F]FDG PET/CT[68Ga]Ga-PSMA-11 PET/CTmetastatic castration-resistant prostate cancerprognosis

Substanzen

Gallium RadioisotopesGallium IsotopesFluorodeoxyglucose F18gallium 68 PSMA-11Heterocyclic Compounds, 1-RingEdetic AcidLutetiumDipeptidesLutetium-177Radioisotopes

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Université Bourgogne Europe, Centre Georges-François Leclerc, Dijon, France.
  • Department of Statistics, Université Bourgogne Europe, Centre Georges-François Leclerc, Dijon, France.
  • Department of Nuclear Medicine, Centre Léon Bérard, Lyon, France.
  • Department of Nuclear Medicine, Centre Oscar Lambret, Lille, France.
  • Department of Nuclear Medicine, ICMUB, UMR CNRS 6302, Université Bourgogne Europe, Centre Georges-François Leclerc, Dijon, France.
  • Centre Georges-François Leclerc, Department of Medical Oncology, Université Bourgogne Europe, Dijon, France.

Zitieren

APA

Jougla, A., Nunes, P., Giraudet, A. L., Olivier, A., Blanc, J., Cochet, A., Ladoire, S., Vrigneaud, J. M., Vija-Racaru, L., & Drouet, C. (2026). Prognostic Value of a Composite Score Incorporating Baseline [ 18 F]FDG PET/CT and [ 68 Ga]Ga-PSMA-11 PET/CT When Screening for [ 177 Lu]Lu-PSMA Treatment Eligibility (PROFILE Study). Journal of Nuclear Medicine, jnumed.126.272368. https://doi.org/10.2967/jnumed.126.272368

Vancouver

Jougla A, Nunes P, Giraudet AL, Olivier A, Blanc J, Cochet A, et al. Prognostic Value of a Composite Score Incorporating Baseline [ 18 F]FDG PET/CT and [ 68 Ga]Ga-PSMA-11 PET/CT When Screening for [ 177 Lu]Lu-PSMA Treatment Eligibility (PROFILE Study). Journal of Nuclear Medicine. 2026:jnumed.126.272368. doi:10.2967/jnumed.126.272368

BibTeX
@article{Jougla2026,
  author = {Jougla, Adrien and Nunes, Prescillia and Giraudet, Anne-Laure and Olivier, Anaïs and Blanc, Julie and Cochet, Alexandre and Ladoire, Sylvain and Vrigneaud, Jean-Marc and Vija-Racaru, Lavinia and Drouet, Clément},
  title = {Prognostic Value of a Composite Score Incorporating Baseline [ 18 F]FDG PET/CT and [ 68 Ga]Ga-PSMA-11 PET/CT When Screening for [ 177 Lu]Lu-PSMA Treatment Eligibility (PROFILE Study)},
  journal = {Journal of Nuclear Medicine},
  year = {2026},
  pages = {jnumed.126.272368},
  doi = {10.2967/jnumed.126.272368}
}
Kostenlos starten →